Imunon (IMNN) Stock Statistics & Valuation Metrics

Imunon has a market cap or net worth of $25.61M. The enterprise value is $4.42M.

Imunon has 17,541,733 shares outstanding. The number of shares has decreased by -2.65% in one year.

Imunon’s return on equity (ROE) is -4.39 and return on invested capital (ROIC) is -355.38%.

The current PE Ratio of Imunon is -0.74. Imunon’s PEG ratio is >-0.01.

In the last 12 months, Imunon had revenue of 0.00 and earned -18.62M in profits. Earnings per share was -1.72.

In the last 12 months, operating cash flow was -15.83M and capital expenditures -277.44K, giving a free cash flow of -16.11M billion.

Imunon pays an annual dividend of ―, resulting in a dividend yield of ―

Imunon upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.

Imunon as a current ratio of 1.67, with Debt / Equity ratio of 21.37%

In the past 12 months, Imunon has paid 0.00 in taxes.

Imunon EV to EBITDA ratio is -0.50, with an EV/FCF ratio of -0.48.

Imunon has $2.87M in cash and marketable securities with $1.01M in debt, giving a net cash position of -$1.86M billion.

Gross margin is -46.33%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Imunon is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy